Journal of Food and Nutrition Research
ISSN (Print): 2333-1119 ISSN (Online): 2333-1240 Website: http://www.sciepub.com/journal/jfnr Editor-in-chief: Prabhat Kumar Mandal
Open Access
Journal Browser
Go
Journal of Food and Nutrition Research. 2017, 5(2), 101-109
DOI: 10.12691/jfnr-5-2-5
Open AccessReview Article

Biomarkers of the Metabolic Syndrome: Influence of Caloric Intake, Various Food Groups and Vitamins

Harry Robberecht1, , Tess De Bruyne1 and Nina Hermans1

1University of Antwerp, Department of Pharmaceutical Sciences, Laboratory of General and Functional Foods, NatuRA (Natural Products and Food-Research and Analysis), Universiteitsplein 1, B-2610, Wilrijk, Belgium

Pub. Date: February 17, 2017

Cite this paper:
Harry Robberecht, Tess De Bruyne and Nina Hermans. Biomarkers of the Metabolic Syndrome: Influence of Caloric Intake, Various Food Groups and Vitamins. Journal of Food and Nutrition Research. 2017; 5(2):101-109. doi: 10.12691/jfnr-5-2-5

Abstract

Influences of caloric intake, various food groups and vitamins on the concentration of biomarkers of the metabolic syndrome (MetS) are reviewed. Since food is a complex mixture of caloric compounds and essential non-caloric food components with multiple interactions and varying bioavailability, it is hard to separate or identify the effect of one single component in a total meal or diet on the biomarkers. Literature data should be studied in detail to conclude whether a component is related to a reduction of MetS-related symptoms or whether its influence is merely affecting a biomarker. Moreover the diet contains various biologically active components, which may add some beneficial characteristics. Therefore, conclusions on the effect of a component on the various biomarkers of MetS are sometimes quite contradictory.

Keywords:
biomarkers metabolic syndrome food groups vitamins

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
 
[2]  Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 1989; 149: 1514-1520.
 
[3]  Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
 
[4]  Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
 
[5]  Lann D, LeRoith D. Insulin resistance as the underlying cause for the metabolic syndrome. Med Clin North Am 2007; 91: 1063-1077.
 
[6]  Onat A, Uyarel H, Hergenç G, et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 2006; 19: 1055-1062.
 
[7]  Festa A, D’Agostino Jr R, Howard C, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47.
 
[8]  Hajer GR, van der Graaf Y, Olijhoek JK, et al. Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart 2007; 93: 216-220.
 
[9]  Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
 
[10]  Mansoub S, Chan MK, Adeli K. Gap analysis of pediatric reference intervals for risk biomarkers of cardiovascular disease and the metabolic syndrome. Clin Biochem 2006; 39: 569-587.
 
[11]  Robberecht H, Hermans N. Biomarkers of the metabolic syndrome: biochemical background and clinical significance. Part 1: dyslipidemias and markers of oxidative stress. Part 2: markers of inflammation and cardio-metabolic biomarkers. Metabolic Syndr and Related Disorders 2016; 14: 1-47.
 
[12]  Robberecht H, De Bruyne T , Hermans N. Biomarkers of the metabolic syndrome: influence of selected foodstuffs with biologically active components. Mol Nutr Food Res, submitted for publication.
 
[13]  Muzio F, Mondazzi L, Sommariva D, et al. Long-term effects of low-calorie diet on the metabolic syndrome in obese nondiabetic patients. Diabetes Care 2005; 28: 1485-148
 
[14]  Devaraj S, Wang-Polagruto J, Polagruto J, et al. High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Metabolism 2008; 57: 867-870.
 
[15]  Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation. Emphasis on the metabolic syndrome. J Amer Coll Cardiol 2006; 48: 677-685.
 
[16]  Jakubowicz D, Barnea M, Wainstein J, et al. High caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women. Obesity 2013; 21: 2504-2512.
 
[17]  Amiti L, Marzulli G, Martulli M, et al. Effects of a hypocaloric diet on obesity biomarkers: prevention of low-grade inflammation since childhood. Curr Pharm Des 2010; 16: 896-897.
 
[18]  Robberecht H, De Bruyne T, Hermans N. Effect of various diets on biomarkers of the metabolic syndrome. Int J Food Sciences Nutr 2016.
 
[19]  Phinney SD. Fatty acids, inflammation, and the metabolic syndrome. Am J Clin Nutr 2005; 82: 1151-1152.
 
[20]  Freire RD, Cardoso MA, Gimeno SG, et al. Dietary fat is associated with metabolic syndrome in Japanese Brazilians. Diabetes Care 2005; 28: 1779-1785.
 
[21]  Melanson EL, Astrup A, Donahoo WT. The relationship between dietary fat and fatty acid intake and body weight, diabetes, and the metabolic syndrome. Ann Nutr Metab 2009; 55: 229-243.
 
[22]  Chien K-L, Chao C-L, Kuo C-H, et al. Plasma fatty acids and the risk of metabolic syndrome in ethnic Chinese adults in Taiwan. Lipids in Health and Disease 2011; 10: 33.
 
[23]  Smilowitz JT, Wiest MM, Teegarden D, et al. Dietary fat and not calcium supplementation or dairy product consumption is associated with changes in anthropometrics during a randomized, placebo-controlled energy-restriction trial. Nutrition and Metabolism 2011; 8: 67. www.nutritionandmetabolism.com/content/8/1/67.
 
[24]  Grundy SM, Abate N, Candalia M. Diet composition and the metabolic syndrome: what is the optimal fat intake ? Am J Med 2002; 113: S25-S29.
 
[25]  Riccardi G, Giacco R, Rivellese AA. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 2004; 23: 447-456.
 
[26]  Sohn C, Kim J, Bae W. The Framingham risk score, diet, and inflammatory markers in Korean men with the metabolic syndrome. Nutr Res Pract 2012; 6: 246-253.
 
[27]  Yamada M, Sasaki S, Murakami K, et al. Association of trans fatty acid intake with metabolic risk factors among free-living young Japanese women. Asia Pac J Clin Nutr 2009; 18: 359-371.
 
[28]  Um Y-J, Oh S-W, Lee C-M, et al. Dietary fat intake and the risk of metabolic syndrome in Korean adults. Korean J Fam Med 2015, 36: 245-252.
 
[29]  Torris C, Molin M, Smastuen MC. Fish consumption and its possible preventive role in the development and prevalence of metabolic syndrome- a systematic review. Diabetol Metab Syndr 2014; 6: 112.
 
[30]  Zaribaf F, Falahi E, Barak F, et al. Fish consumption is inversely associated with the metabolic syndrome. Eur J Clin Nutr 2014; 68: 474-480.
 
[31]  Simao AN, Lozovoy MA, Bahls LD, et al. Blood pressure decrease with ingestion of soya product (kinako) or fish oil in women with the metabolic syndrome: role of adiponectin and nitric oxide. Br J Nutr 2012; 108: 1435-1442.
 
[32]  Pedersen MH, Molgaard C, Hellgren LI, et al. Effects of fish oil supplementation on markers of the metabolic syndrome. J Pediatr 2010; 157: 395-400.
 
[33]  Chan DC, Watts GF, Mori TA, et al. Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity. Eur J Clin Invest 2002; 32: 1694-1704.
 
[34]  Al-Gayyar MM, Shams ME, Barakat EA. Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: impact of nonalcoholic fatty liver disease. Pharm Biol 2012; 50: 297-303.
 
[35]  Lee TC, Ivester P, Hester AG, et al. The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population. Lipids in Health and Disease 2014; 13: 196.
 
[36]  Venturini D, Simao AN, Urbano MR, et al. Effects of extra virgin olive oil and fish oil on lipid profile and oxidative stress in patients with metabolic syndrome. Nutr 2015; 31: 834-840.
 
[37]  Jones W, Scott D, Lodge JK, et al. The effect of fish oil versus krill oil on markers of metabolic syndrome and the plasma metabolome; a pilot study. Proceedings of the Nutrition Society 2012; 71 (OCE2) E67.
 
[38]  Root M, Collier SR, Zwetsloot KA, et al. A randomized trial of fish oil omega-3 fatty acids on arterial health, inflammation, and metabolic syndrome in a young healthy population. Nutr J 2013; 12: 40.
 
[39]  Ulven SM, Kirkhus B, Lamglait A, et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids 2011; 46: 37-46.
 
[40]  Lee TC, Ivester P, Hester AG, et al. The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population. Lipids in Health and Disease 2014; 13: 196. www.lipidworld.wom/content/13/1/196.
 
[41]  Hanhineva K, Lankinen MA, Pedret A, et al. Nontargeted metabolite profiling discriminates diet-specific biomarkers for consumption of whole grains, fatty fish, and bilberries in a randomized controlled trial. J Nutr 2014.
 
[42]  Carpentier YA, Portois L, Malaisse WJ. n—3 fatty acids and the metabolic syndrome. Am J Clin Nutr 2006; 83: 1499S-1504S.
 
[43]  Gillingham LG, Harris-Janz S, Jones PJH. Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids 2011; 46: 209-228.
 
[44]  Hosseinpour-Niazi S, Mirmiran P, Fallah-Ghohroudi A, et al. Combined effect of unsaturated fatty acids and saturated fatty acids on the metabolic syndrome: Tehran lipid and glucose study. J Health, Population and Nutr 2015; 33: 5.
 
[45]  Lorente-Cebrian S, Costa AG, Navas-Carretero S, et al. Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. J Physiol Biochem 2013; 69: 633-651.
 
[46]  Poudyal H, Panchal SK, Diwan V, et al. Omega-3 fatty acids and metabolic syndrome: effects of emerging mechanisms of action. Progress in Lipid Res 2011; 50: 372-387.
 
[47]  Baik I, Abbott RD, Curb JD, et al. Intake of fish and n-3 fatty acids and future risk of metabolic syndrome. J Am Diet Assoc 2010; 110: 1018-1026.
 
[48]  Cabello-Saavendra E, Bes-Rastrollo M, Martinez JA. Macronutrient intake and metabolic syndrome among high cardiovascular risk subjects. Ann Rev Metab 2010; 56: 152-159.
 
[49]  Troseid M, Arnesen H, Hjerkinn EM, et al. Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men. Metabolism 2009; 58: 1543-1549.
 
[50]  Mayneris-Perachs J, Sala-Vila A, Chisaquano M, et al. Effects of 1-year intervention with a Mediterranean diet on plasma fatty acid composition and metabolic syndrome in a population at high cardiovascular risk. PLoS One 2014; 9: e85202.
 
[51]  Laake K, Seljeflot I, Fagerland MW, et al. Effects on serum fractalkine by diet and omega-3 fatty acid intervention: relation to clinical outcome. Mediators Inflamm 2015.
 
[52]  Meckling KA, Sherfey R. A randomized trial of a hypocaloric high-protein diet, with and without exercise, on weight loss, fitness, and markers of the metabolic syndrome in overweight and obese women. Appl Physiol Nutr Metab 2007; 32: 743-752.
 
[53]  Reaven GM. Do high-carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against. Curr Opin Lipidol 1997; 8: 23-27.
 
[54]  Aude YW, Mego P, Metha JL. Metabolic syndrome: dietary interventions. Curr Opin Cardiol 2004; 19: 473-479.
 
[55]  Reinehr T, Roth CL, Alexy U, et al. Ghrelin levels before and after reduction of overweight due to a low-fat high carbohydrate diet in obese children and adolescents. Int J Obes 2005; 29: 362-368.
 
[56]  Poppitt SD, Keogh GF, Prentice AM, et al. Long-term effects of ad libitum low-fat, high carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome. Am J Clin Nutr 2002; 75: 11-20.
 
[57]  Volk BM, Kunces LJ, Freidenreich DJ, et al. Effects of step-wise increases in dietary carbohydrate on circulating saturated fatty acids and palmitoleic acid in adults with metabolic syndrome. PLoS ONE 2014; 9:e113605.
 
[58]  Chan T-F, Lin W-T, Huang H-L, et al. Consumption of sugar-sweetened beverages is associated with components of the metabolic syndrome in adolescents. Nutrients 2014; 6: 2088-2103.
 
[59]  Malik VS, Popkin BM, Bray GA, et al. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes. Diabetes Care 2010; 33: 2477-2483.
 
[60]  Mattei J, Malik V, Hu FB, et al. Substituting homemade fruit juice for sugar-sweetened beverages is associated with lower odds of metabolic syndrome among Hispanic adults. J Nutr 2012; 142: 1081-1087.
 
[61]  Volek JS, Feinman RD. Carbohydrate restriction improves the features of metabolic syndrome. Metabolic syndrome may be defined by the response to carbohydrate restriction. Nutr and Metab 2005; 3:31.
 
[62]  Accurso A, Bernstein RK, Dahlqvist A, et al. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr and Metab 2008; 5:9.
 
[63]  Al-Sarraj T, Saadi H, Calle MC, et al. Carbohydrate restriction, as a first-line dietary intervention, effectively reduces biomarkers of metabolic syndrome in Emirati adults. J Nutr 2009; 139: 1667-1676.
 
[64]  Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr and Metab 2005; 2:5.
 
[65]  Johnson RJ, Segal MS, Sautin Y, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007; 86: 899-906.
 
[66]  Millar A, Adeli K. Dietary fructose and the metabolic syndrome. Curr Opin Gastroenterol 2008; 24: 204-209.
 
[67]  Bantle JP. Dietary fructose and metabolic syndrome and diabetes. J Nutr 2009; 139: 1263S-1268S.
 
[68]  Hosseini-Esfahani F, Bahadoran Z, Mirmiran P, et al. Dietary fructose and risk of metabolic syndrome in adults: Tehran Lipid and Glucose study. Nutr and Metab 2011; 8: 50.
 
[69]  Reiser S, Powell AS, Schofield DJ, et al. Blood lipids, lipoproteins, apoproteins, and uric acid in men fed diets containing fructose or high-amylose cornstarch. Am J Clin Nutr 1989; 49: 832-839.
 
[70]  Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290: F625-F631.
 
[71]  Perez-Pozo SE, Schold J, Nakagawa T, et al. Excessive fructose intake induces features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes 2010; 34: 454-461.
 
[72]  Khitan Z, Kim DH. Fructose: a key factor in the development of metabolic syndrome and hypertension. J Nutr Metabol 2013; article ID 682673.
 
[73]  McKeown NM, Meigs JB, Liu S, et al. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care 2004; 27: 538-546.
 
[74]  Lares M, Perez E, Schroeder M, et al. Biochemical and anthropometric markers, metabolic syndrome and main dietary habits of Waraos population sample. Food Nutr Sci 2011; 2: 444-450.
 
[75]  Carlson JJ, Eisenmann JC, Norman GJ, et al. Dietary fiber and nutrient density are inversely associated with the metabolic syndrome in US adolescents. J Am Diet Assoc 2011; 111: 1688-1695.
 
[76]  Cabello-Saavedra E, Bes-Rastrollo M, Martinez JA, et al. Macronutrient intake and metabolic syndrome in subjects at high cardiovascular risk. Ann Nutr Metab 2010; 56: 152-159.
 
[77]  Hosseinpour-Niazi S, Mirmiran P, Sohrab G, et al. Inverse association between fruit, legume, and cereal fiber and the risk of metabolic syndrome: Tehran Lipid and Glucose Study. Diabetes Res Clin Practice 2011; 94: 276-283.
 
[78]  Hosseinpur-Niazi S, Mirmiran P, Mirzaei S, et al. Cereal, fruit and vegetable fibre intake and the risk of the metabolic syndrome: a prospective study in the Tehran Lipid and Glucose Study. J Hum Nutr Diet 2014; 28: 236-245.
 
[79]  Amaya A, Marta M. Dietary fiber in the prevention and treatment of metabolic syndrome: a review. Crit Rev Food Sci and Nutr 2008; 48: 905-912.
 
[80]  Hollaender PLB, Ross AB, Kristensen M. Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies. Am J Clin Nutr 2015; 102: 556-572.
 
[81]  El Shebini SM, Moaty MIA, Tapozada ST, et al. Effect of whole wheat (Triticuma estivum) and oat (Avena sativa) supplements on body weight, insulin resistance and circulating omentin in obese women exhibiting metabolic syndrome criteria. World J Med Sciences 2014; 11: 373-381.
 
[82]  Ross AB, BourgeoisA, Macharia HN, et al. Plasma alkylresorcinols as a biomarker of whole-grain food consumption in a large population: results from the WHOLEheart Intervention Study. Am J Clin Nutr 2012; 95: 204-211.
 
[83]  Magnusdottir OK, Landberg R, Gunnarsdottir I, et al. Plasma alkylresorcinols C17:0/C21:0 ratio, a biomarker of relative whole-grain rye intake, is associated tot insulin sensitivity: a randomized study. Eur J Clin Nutr 2014; 68: 453-458.
 
[84]  Magnusdottir OK, Landberg R, Gunnarsdottir I, et al. Whole grain rye intake, reflected by a biomarker, is associated with favorable blood lipid outcomes in subjects with the metabolic syndrome-a randomized study. PLoS One 2014; 9; e110827.
 
[85]  MacArthur M, Magnanti S, Landberg R, et al. Plasma alkylresorcinols as a biomarker for whole grain intake and predictor of metabolic syndrome risk. FASEB J 2015. http:// www.fasebj.org/content/29/1_Supplement/606.8.
 
[86]  Zheng L, Zou L, Xia J. Can we consider plasma alkylresorcinols as a potential biomarker of whole-grain food ? Am J Clin Nutr 2012; 96: 1150-1151.
 
[87]  Ma J, Ross AB, Shea MK, et al. Plasma alkylresorcinols, biomarkers of whole-grain intake, are related to lower BMI in older adults. J Nutr 2012; 142: 1859-1864.
 
[88]  Mello VD, Laaksonen DE. Dietary fibers: current trends and health benefits in the metabolic syndrome and type 2 diabetes. Arq Bras Endocrinol Metabol 2009; 53: 509-518. Abstract in English.
 
[89]  Galisteo M, Duarte J, Zarzuelo A. Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem 2008; 19: 71-84.
 
[90]  Hosseinpour-Niazi S, Mirmiran P, Amiri Z, et al. Dietary legumes intake and metabolic syndrome and its components in adults. Iran J Endocrinol Metab 2011; 12: 594-602.
 
[91]  Hosseinpour-Niazi S, Mirmiran P, Sohrab G, et al. Inverse association between fruit, legume, and cereal fiber and the risk of metabolic syndrome: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2011; 94: 276-283.
 
[92]  Hosseinpour-Niazi S, Mirmiran P, Amiri Z, et al. Legume intake is inversely associated with metabolic syndrome in adults. Arch Iranian Med 2012; 15: 538-544.
 
[93]  Sajjadi F, Gharipour M, Mohammadifard N, et al. Relationship between legumes consumption and metabolic syndrome: findings of the Isfahan Healthy Heart Program. ARYA Atheroscler 2014; 10: 18-24.
 
[94]  Alizadeh M, Gharaaghaji R, Gargari BP. The effects of legumes on metabolic features, insulin resistance and hepatic function tests in women with central obesity: a randomized controlled trial. Int J Prev Med 2014; 5: 710-720.
 
[95]  Esmaillzadeh A, Azadbakht L. Legume consumption is inversely associated with serum concentrations of adhesion molecules and inflammatory biomarkers among Iranian women. J Nutr 2012; 142: 334-339.
 
[96]  Sarah-Bank S, Esmaillzadeh A, Faghihimani E, et al. Effect of non-soy legume consumption on inflammation and serum adiponection levels among first-degree relatives of patients with diabetes: a randomized, crossover study. Nutr 2015: 31: 459-465.
 
[97]  Hill AM, Jackson KAH, Roussell MA, et al. Type and amount of dietary protein in the treatment of metabolic syndrome: a randomized controlled trial. Am J Clin Nutr 2015; 102: 757-770.
 
[98]  Tang M, Armstrong CLH, Leidy HJ, et al. Normal vs. high-protein weight loss diets in men: effects on body consumption and indices of metabolic syndrome. Obesity 2013; 21: E204-E210.
 
[99]  Dutheil F, Lac G, Coureix D, et al. Treatment of metabolic syndrome by combination of physical activity and diet needs an optimal protein intake: a randomized controlled trial. Nutr J 2012; 11:72.
 
[100]  Fujita N, Takei Y. Alcohol consumption and metabolic syndrome. Hepatol Res 2011; 41: 287-295.
 
[101]  Alkerwi A, Boutsen M, Vaillant M, et al. Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies. Atherosclerosis 2008.
 
[102]  Gigleux I, Gagnon J, St-Pierre A, et al. Moderate alcohol consumption is more cardioprotective in men with the metabolic syndrome. J Nutr 2006; 136: 3027-3032.
 
[103]  Athyros VG, Liberopoulos EN, Mikhailidis DP, et al. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort. Angiology 2007; 58: 689-697.
 
[104]  Sun K, Ren M, Liu D, et al. Alcohol consumption and risk of metabolic syndrome: a meta-analysis of prospective studies. Clin Nutr 2014; 33: 596-602.
 
[105]  Koloverou E, Panagiotakos DB, Pitsavos C, et al. Effects of alcohol consumption and the metabolic syndrome on 10-year incidence of diabetes: the ATTICA study. Diabetes and Metabolism 2015; 41: 152-159.
 
[106]  Nakajima K, Saito M. Vague relationship between alcohol consumption and metabolic syndrome in nonobese people. World J Gastroenterol 2012; 18: 5315-5316.
 
[107]  Djoussé L, Arnett DK, Eckfeldt JH, et al. Alcohol consumption and metabolic syndrome: does the type of beverage matter? Obesity Res 2004; 12: 1375-1385.
 
[108]  Freiberg MS, Cabral HJ, Heeren TC, et al. Alcohol consumption and the prevalence of the metabolic syndrome in the U.S. A cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2954-2959.
 
[109]  Yoon YS Oh SW, Baik HW, et al. Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination. Am J Clin Nutr 2004; 80: 217-224.
 
[110]  Sun K, Ren M, Liu D, et al. Alcohol consumption and risk of metabolic syndrome: a meta-analysis of prospective studies. Clin Nutr 2014; 33: 596-602.
 
[111]  Baik I, Shin C. Prospective study of alcohol consumption and metabolic syndrome. Am J Clin Nutr 2008; 87: 1455-1463.
 
[112]  Vincente-Herrero MT, Lopez Gonzalez AA, Ramirez-Iniguez de la Torre MV, et al. Cardiovascular risk parameters, metabolic syndrome and alcohol consumption by workers. Endocrinol Nutr 2015; 62: 161-167.
 
[113]  Hamaguchi M, Kojima T, Ohbora A, et al. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol 2012; 14: 156-167.
 
[114]  Yu M, Xu C-X, Zhu H-H, et al. Associations of cigarette smoking and alcohol consumption with metabolic syndrome in a male Chinese population: a cross-sectional study. J Epidemiol 2014; 24: 361-369.
 
[115]  Stoutenberg M, Lee D, Sui X, et al. Prospective study of alcohol consumption and the incidence of the metabolic syndrome in US men. Br J Nutr 2013; 110: 901-910.
 
[116]  Buja A, Scafato E, Sergi G, et al. Alcohol consumption and metabolic syndrome in the elderly: results from the Italian longitudinal study on aging. Eur J Clin Nutr 2010; 64: 297-307.
 
[117]  Pischon T, Girman CJ, Rifai N, et al. Association between dietary factors and plasma adiponectin concentrations in men. Am J Clin Nutr 2005; 81: 780-786.
 
[118]  Xiao J, Huang J-P, Xu G-F, et al. Association of alcohol consumption and components of metabolic syndrome among people in rural China. Nutr and Metab 2015; 12:5.
 
[119]  Stiburkova B, Pavlikova M, Sokolova J, et al. Metabolic syndrome, alcohol consumption and genetic factors are associated with serum uric acid concentration. PLoS ONE 2014; 9(5): e97646.
 
[120]  Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome “X”? Br J Nutr 1998; 79: 315-327.
 
[121]  Chiu KC, Chu A, Go VL, et al. Hypovitaminose D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-825.
 
[122]  Ford ES, Ajani UA, McGuire LC, et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005; 28: 1228-1230.
 
[123]  Hyppönen E, Boucher BJ, Berry DJ, et al. 25-hydroxyvitamin D, IGF-1, and the metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008; 57: 298-305.
 
[124]  Kim MK, Moo K, Ki Won O, et al. The association of serum D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol 2010; 73: 330-338.
 
[125]  Salekzamani S, Neyestani TR, Alavi-Majd H, et al. Is vitamin D status a determing factor for metabolic syndrome ? A case-control study. Diabetes Metab Syndr Obes 2011; 4: 205-212.
 
[126]  Chacko SA, Song Y, Manson JE, et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 2011; 94: 209-217.
 
[127]  Muldowney S, Kiely M. Vitamin D and cardiometabolic health: a review of the evidence. Nutr Res Rev 2011; 24: 1-20.
 
[128]  Yin X, Sun Q, Zhang X, et al. Serum 25(OH)D is inversely associated with metabolic syndrome risk profile among urban middle-aged Chinese population. Nutr J 2012; 11: 68.
 
[129]  Baker JF, Mehta NN, Baker DG, et al. Vitamin D, metabolic dyslipidemia, and metabolic syndrome in rheumatoid arthritis. Am J Med 2012; 125: 1036.e9-1036.e15.
 
[130]  Barchetta I, De Bernardinis M, Capoccia D, et al. Hypovitaminosis D is independently associated with metabolic syndrome in obese patients. PLoS 2013; 8: e68689.
 
[131]  Lee SH, Kim SM, Park HS, et al. Serum 25-hydroxyvitamin D levels, obesity and the metabolic syndrome among Korean children. Nutr Metab Cardiovasc Dis 2013: 23: 785-791.
 
[132]  Mitri J, Nelson J, Ruthazer R, et al. Plasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program. Eur J Clin Nutr 2014; 68: 376-383.
 
[133]  Huang CY, Chang HH, Lu CW, et al. Vitamin D status and the risk of metabolic syndrome among non-diabetic young adults. Clin Nutr 2015; 34: 484-489.
 
[134]  Kim J. Association between serum vitamin D, parathyroid hormone and metabolic syndrome in middle-aged and older Korean adults. Eur J Clin Nutr 2015; 69: 425-430.
 
[135]  Challa AS, Makariou SE, Siomou EC. The relation of vitamin D status with metabolic syndrome in childhood and adolescence: an update. J Pediatr Endocrinol Metab 2015.
 
[136]  Ahmadi F, Damghani S, Lessan-Pezeshki M, et al. Association of low vitamin D levels with metabolic syndrome in hemodialysis patients. Hemodial Int 2015.
 
[137]  Lee DY, Kwon AR, Ahn JM, et al. Relationship between serum 25-hydroxyvitamin D concentration and risks of metabolic syndrome in children and adolescents from Korean National Health and Nutrition Examination survey 2008-2010. Ann Pediatr Endocrinol Metab 2015; 20: 46-52.
 
[138]  Prasad D, Kochhar A. Interplay of vitamin D and metabolic syndrome: a review. Diabetes Metab Syndr 2015.
 
[139]  Liu S, Song Y, Ford ES, et al. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2007; 28: 2926-2932.
 
[140]  Maki KC, Rubin MR, Wong LG, et al. Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipidol 2009; 3: 289-296.
 
[141]  Song HR, Park CH. Low serum vitamin D level is associated with high risk of metabolic syndrome in post-menopausal women. J Endocrinol Invest 2013; 36: 791-796.
 
[142]  Chon SJ, Yun BH, Jung YS, et al. Association between vitamin D status and risk of metabolic syndrome among Korean post-menopausal women. PLoS One 2014; 9: e89721.
 
[143]  De Piero Belmonte A, Rodriguez-Rodriguez E, Gonzalez-Rodriguez LG, et al. Serum vitamin D and metabolic risk factors in a group of Spanish schoolchildren. Nutr Hosp 2014; 31: 1154-1162 (Abstract in English).
 
[144]  Yasein N, Shroukh W, Hijawi R. Serum vitamin D and the metabolic syndrome among osteoporotic postmenopausal female patients of a family practice clinic in Jordan. Adv Clin Exp Med 2015; 24: 245-250.
 
[145]  Vitezova A, Zillekens MC, van Herpt TT, et al. Vitamin D status and metabolic syndrome in elderly: the Rotterdam study. Eur J Endocrinol 2015; 172: 327-335.
 
[146]  Petersen RA, Dalskov S-M, Sorensen LB, et al. Vitamin D status is associated with cardiometabolic markers in 8-11-year-old children, independently of body fat and physical activity. Br J Nutr 2015; 114: 1647-1655.
 
[147]  Gulseth HL, Gjelstad IMF, Tierney AC, et al. Serum vitamin D concentration does not predict insulin action or secretion in European subject with the metabolic syndrome. Diabetes Care 2010; 33: 923-925.
 
[148]  Gulseth HL, Gjelstad IM, Birdeland KI, et al. Vitamin D and the metabolic syndrome. Curr Vasc Pharmacol 2013; 11: 968-984.
 
[149]  Kelishadi R, Saled S, Salek M, et al. Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial. J Pediatr 2014; 90: 28-34.
 
[150]  Sansanayudh N, Wongwiwatthananukit S, Phetkrajaysang N, et al. Comparative efficacy and safety of different doses of ergocalciferol supplementation in patients with metabolic syndrome. Int J Clin Pharm 2014.
 
[151]  Rafraf M, Hasanabad SK, Jafarabadi MA. Vitamin D status and its relationship with metabolic syndrome risk factors among adolescent girls in Boukan, Iran. Public Health Nutr 2014; 17: 803-809.
 
[152]  Vasmehjani AA, Paknahad Z, Maracy MR. Association of dietary vitamin D, serum 25-hydroxyvitamin D, insulin-like growth factor-1 concentrations and components of metabolic syndrome among Iranian women. Adv Biomed Res 2014; 3: 159.
 
[153]  Ju SY, Jeong HS, Kim DH. Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis. J Clin Endocrinol Metab 2014; 99: 1053-1063.
 
[154]  Jialal I, Devaraj S. Scientific evidence to support a vitamin E and heart disease health claim: research needs. J Nutr 2005; 135: 348-353.
 
[155]  Hathcock JN, Azzi A, Blumberg J, et al. Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr 2005; 81: 736-745.
 
[156]  Devaraj S, Leonard S, Traber MG, et al. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med 2008; 44: 1203-1208.
 
[157]  Sempértegui F, Estrella B, Tucker KL, et al. Metabolic syndrome in the elderly living in marginal peri-urban communities in Quito, Ecuador. Public Health Nutr 2011; 14: 758-767.
 
[158]  Yen CH, Yang NC, Lee BJ, et al. The antioxidant status and concentrations of coenzyme Q10 and vitamin E in metabolic syndrome. Scientific World Journal 2013: 767968.
 
[159]  Godala M, Materek-Kusmierkiewicz, Moczulski D, et al. Physical activity in patients with symptoms of metabolic syndrome reduces the concentration of plasma antioxidant vitamins-prospective effect of vitamin C. Pol Merkur Lekarski 2015; 38: 258-262. (Abstract in English).
 
[160]  Wang Q, Sun Y, Ma A, Li Y, Han X, et al. Effects of vitamin E on plasma lipid status and oxidative stress in Chinese women with metabolic syndrome. Int J Vitam Nutr Res 2010; 80: 178-187.
 
[161]  Park S, Ham JO, Lee BK. Effects of total vitamin A, vitamin C, and fruit intake on risk for metabolic syndrome in Korean women and men. Nutrition 2015; 31: 111-118.
 
[162]  Gao M, Zhao Z, Lv P, et al. Quantitative combination of natural anti-oxidants prevents metabolic syndrome by reducing oxidative stress. Redox Biol 2015; 6: 206-217.
 
[163]  Sebekova K, Boor P, Valachovicova M, et al. Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians. Mol Nutr Food Res 2006; 50: 858-868.
 
[164]  Godala M, Materek-Kusmierkiewicz, Moczulski D, et al. Physical activity in patients with symptoms of metabolic syndrome reduces the concentration of plasma antioxidant vitamins-prospective effect of vitamin C. Pol Merkur Lekarski 2015; 38:258-262. (Abstract in English).
 
[165]  Kim J, Choi YH. Physical activity, dietary vitamin C, and metabolic syndrome in Korean adults: the Korea National Health and Nutrition Examination Survey 2008 to 2012. Public Health 2016.
 
[166]  Pan Y, Jackson RT. Dietary phylloquinone intakes and metabolic syndrome in US young adults. J Am Coll Nutr 2009; 28: 369-379.
 
[167]  Dam V, Dalmeijer GW, Vermeer C, et al. Association between vitamin K and the metabolic syndrome: a 10-year follow-up study in adults. J Clin Endocrinol Metab 2015; 100: 2472-2479.
 
[168]  Suriyaprom K, Phonrat B, Satitvipawee P, et al. Homocysteine but not serum amyloid A, vitamin A and E related to increased risk of metabolic syndrome in post-menopausal Thai women. Int J Vitam Nutr Res 2014, 84: 35-44.
 
[169]  Setola E, Monti LD, Galluccio E, et al. Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 2004; 151: 483-489.
 
[170]  Hayden MR, Tyagi SC. Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atherosclerotherapy: the pleiotropic effects of folate supplementation. Nutr J 2004; 3:4.
 
[171]  Godsland IF, Rosankiewicz JR, Proudler AJ, et al. Plasma total homocysteine concentrations are unrelated to insulin activity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 2001;86: 719-723.
 
[172]  Meigs JB, Jacques PF, Selhub J, et al. Fasting plasma total homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001; 24: 1403-1410.
 
[173]  Sanchez-Margalet V, Valle M, Ruz FJ, et al. Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. J Nutr Biochem 2002; 13: 75-79.
 
[174]  Catena C, Colussi G, Nait F, et al. Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients. Am J Hypertens 2015; 28: 943-950.
 
[175]  Bruscato NM, Vieira JL, do Nascimento NM, et al. Dietary intake is not associated to the metabolic syndrome in elderly women. N Am J Med Sci 2010; 2: 182-188.
 
[176]  Bian S, Gao Y, Zhang M, et al. Dietary nutrient intake and metabolic syndrome risk in Chinese adults: a case-control study. Nutr J 2013; 12: 106.
 
[177]  Baltaci D, Kutlucan A, Turker Y, et al. Association of vitamin B12 with obesity, overweight, insulin resistance and metabolic syndrome, and body fat composition; primary care-based study. Med Glas 2013; 10: 203-210.
 
[178]  Motamed S, Ebrahimi M, Safarian M, et al. Micronutrient intake and the presence of the metabolic syndrome. N Am J Med Sci 2013; 5: 377-385.
 
[179]  Jeon KJ, Lee O, Kim HK, Comparison of the dietary intake and clinical characteristics of obese and normal weight adults. Nutr Res Pract 2011; 5: 329-336.
 
[180]  Wilson PWF, D’Agostino RB, Parise H, et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066-3072.
 
[181]  Kaur J. A comprehensive review on metabolic syndrome. Cardiology Res and Practice 2014: article ID 943162.